Fernández-Rivas Montserrat, Bolhaar Suzanne, González-Mancebo Eloina, Asero Riccardo, van Leeuwen Astrid, Bohle Barbara, Ma Yan, Ebner Christof, Rigby Neil, Sancho Ana I, Miles Susan, Zuidmeer Laurian, Knulst André, Breiteneder Heimo, Mills Clare, Hoffmann-Sommergruber Karin, van Ree Ronald
Allergy Unit, Fundación Hospital Alcorcón, Madrid.
J Allergy Clin Immunol. 2006 Aug;118(2):481-8. doi: 10.1016/j.jaci.2006.05.012. Epub 2006 Jun 27.
Allergy to a plant food can either result from direct sensitization to that food or from primary sensitization to pollen, latex, or another food.
We sought to investigate the primary sensitizers in apple allergy across Europe, the individual allergens involved, and whether these differences determine the clinical presentation.
Patients (n = 389) with positive case histories and skin prick test responses to fresh apple were selected in the Netherlands, Austria, Italy, and Spain. Skin prick tests and RASTs to a panel of pollens and plant foods were performed, as well as RASTs to Bet v 1 and the apple allergens Mal d 1, 2, 3, and 4.
In the Netherlands, Austria, and Italy apple allergy is mild (>90% isolated oral symptoms) and related to birch pollinosis and sensitization to Bet v 1 and its apple homologue, Mal d 1, which has an odds ratio of local reactions of 2.85 (95% CI, 1.47-5.55). In Spain apple allergy is severe (>35% systemic reactions) and related to peach allergy and sensitization to Mal d 3 (nonspecific lipid transfer protein), which has an odds ratio of systemic reactions of 7.76 (95% CI, 3.87-15.56).
The analysis of individual apple allergens in a clinical context has provided insight into the sensitization pathway and into the intrinsic risk an allergen bears to induce mild or severe food allergy.
Information on the sensitization pathway is essential to develop preventive strategies in food allergy. The application of individual food allergens with a known intrinsic risk will improve the prognostic value of diagnostic tests.
对植物性食物的过敏既可能源于对该食物的直接致敏,也可能源于对花粉、乳胶或其他食物的原发性致敏。
我们试图调查欧洲范围内苹果过敏的原发性致敏原、涉及的个别过敏原,以及这些差异是否决定临床表现。
在荷兰、奥地利、意大利和西班牙选取有新鲜苹果阳性病史且皮肤点刺试验呈阳性反应的患者(n = 389)。对一组花粉和植物性食物进行皮肤点刺试验和放射性变应原吸附试验(RAST),同时对Bet v 1以及苹果过敏原Mal d 1、2、3和4进行RAST。
在荷兰、奥地利和意大利,苹果过敏症状较轻(>90%为单纯口腔症状),与桦树花粉症以及对Bet v 1及其苹果同源物Mal d 1的致敏有关,Mal d 1引起局部反应的优势比为2.85(95%置信区间,1.47 - 5.55)。在西班牙,苹果过敏症状严重(>35%为全身反应),与桃子过敏以及对Mal d 3(非特异性脂质转移蛋白)的致敏有关,Mal d 3引起全身反应的优势比为7.76(95%置信区间,3.87 - 15.56)。
在临床背景下对个别苹果过敏原的分析为致敏途径以及过敏原引发轻度或重度食物过敏的内在风险提供了深入了解。
致敏途径的信息对于制定食物过敏的预防策略至关重要。应用具有已知内在风险的个别食物过敏原将提高诊断测试的预后价值。